Telix Pharmaceuticals Limited

Status: Publicly traded

Last reviewed: October 2026

Direct answer

Telix Pharmaceuticals Limited is publicly traded on NASDAQ under the ticker TLX.

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3...

Can you invest in Telix Pharmaceuticals Limited?

Yes. Telix Pharmaceuticals Limited trades publicly on NASDAQ as TLX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Telix Pharmaceuticals Limited

Detailed equity research is provided by MarketSnap.